Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)

NCT ID: NCT05416723

Last Updated: 2022-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

302 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-01

Study Completion Date

2022-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to identify specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified by questioning, geographical distribution of cases) from the RNV3P data.

The secondary objectives are as follows:

* Description of cases of ANCA vasculitis seen in French occupational pathology consultation centres:

* reasons for consultation,
* occupational and environmental etiologies described
* occupational situations responsible
* aptitude notices
* recognition as an occupational disease
* Identification of specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified on questioning, geographical distribution of cases).
* For occupational and non-occupational cases of ANCA vasculitis: identification of difficulties encountered by patients at work and proposed work adaptations.
* Estimation of the number of applications for recognition of disabled worker status made within this patient group.
* Identification of clinical severity and autoimmune profiles of ANCA vasculitis of occupational and/or environmental origin.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ANCA Associated Vasculitis Occupational Diseases Environmental Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with ANCA vasculitis defined according to the International Classification of Diseases (ICD-10), i.e. M 308, M 31, N 057 and L 95, or mentioned as the reason for consultation in the text mining summary.
* Seen in consultation in the occupational disease consultation centres belonging to the RNV3P
* No opposition

Exclusion Criteria

* Refusal to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Bordeaux

Bordeaux, , France

Site Status

CHU de Grenoble

Grenoble, , France

Site Status

CHU de LILLE

Lille, , France

Site Status

HCL

Lyon, , France

Site Status

AP-HM

Marseille, , France

Site Status

CHU de Nancy

Nancy, , France

Site Status

CHU de Nantes

Nantes, , France

Site Status

Hôpital Cochin ( AP-HP)

Paris, , France

Site Status

CHU de Rennes

Rennes, , France

Site Status

CHU de Strasbourg

Strasbourg, , France

Site Status

CHU de Toulouse

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Greta GOURIER

Role: CONTACT

0298223509

Brice LODDE

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Esquer Catherine

Role: primary

Bonneterre Vincent

Role: primary

Nisse Catherine

Role: primary

Charbotel Barbara

Role: primary

Lehucher Marie-Pascale

Role: primary

Thaon Isabelle

Role: primary

Tripodi Dominique

Role: primary

Lynda Bensefas-Colas

Role: primary

Paris Christophe

Role: primary

Gonzalez Maria

Role: primary

Esquirol Yolande

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANCAPRO (29BRC22.0035)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pediatric Vasculitis Initiative
NCT02006134 RECRUITING
Abatacept in ANCA Associated Vasculitis
NCT00482066 TERMINATED PHASE2